|
?:authorAffiliation
|
-
[\'Wilhelminen Cancer Research Institute, First Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria. Electronic address: heinz.ludwig@extern.gesundheitsverbund.at.\', \'Erasmus Medical Center Cancer Institute-Erasmus University Rotterdam, Rotterdam, Netherlands.\', \'University of Lille, CHU Lille, Service des Maladies du Sang, Lille, France.\', \'Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain.\', \'Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.\', \'Service d\'Hematologie Clinique et Therapie Cellulaire, Hopital Saint-Antoine, Assistance Publique-Hopitaux de Paris (AP-HP), Sorbonne University, INSERM Unite Mixte de Recherche (UMR) 938, Paris, France.\', \'Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca, Instituto de Biología Molecular y Celular del Cáncer (Universidad de Salamanca-Consejo Superior de Investigaciones Científicas), CIBERONC, Salamanca, Spain.\', \'Department of Hematology, University hospital Hotel-Dieu, Nantes, France.\', \'IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia \'Seràgnoli\', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.\', \'Institute of Cancer Research, London, UK; Royal Marsden Hospital, London, UK.\', \'Department of Hematology, Amsterdam UMC, VU University, Amsterdam, Netherlands.\', \'Department of Medicine I and Department of Hematology, Oncology, and Stem-Cell Transplantation, Clinical Cancer Research Group, University Hospital of Freiburg, Freiburg, Germany.\', \'Department of Oncology and Hematology, Kantonsspital St Gallen, St Gallen, Switzerland.\', \'Leeds Institute of Clinical Trial Research, University of Leeds, Leeds, UK.\', \'Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.\', \'Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy.\', \'Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.\', \'Leuven Cancer Institute, Leuven, Belgium.\', \'Department of Hematology, CHU de Liège, Liège, Belgium.\', \'Universitätsklinikum Hamburg-Eppendorf II, Medizinische Klinik und Poliklinik, Hamburg, Germany.\', \'Northern Centre for Cancer Care, Freeman Hospital, Newcastle Upon Tyne Hospitals trust, Newcastle Upon Tyne, UK.\', \'Sorbonne Université-INSERM, UMR-S 938, Centre de Recherche Saint-Antoine-Team Hematopoietic and leukemic development, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpetrière, Département d\'Hématologie et de Thérapie Cellulaire, Paris, France.\', \'CHU Poitiers, Poitiers, France; Inserm, Poitiers, France.\', \'University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.\', \'Department of Hematology, Ankara University, Ankara, Turkey.\', \'First Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria.\', \'Hematology Research Unit, Department of Hematology, Odense University Hospital, and Department of Clinical Research, University of Southern Denmark, Odense, Denmark.\', \'Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.\', \'Oslo Myeloma Center, Oslo University Hospital Oslo, Norway.\', \'KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway; European Myeloma Network (EMN) Italy, Torino, Italy.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}